METHOD FOR IMPROVING ANTIBODY STABILITY Russian patent published in 2020 - IPC G01N33/68 G16B15/00 G16C99/00 

Abstract RU 2711719 C2

FIELD: biochemistry.

SUBSTANCE: invention relates to biochemistry, particularly to a method of selecting one or more antibodies resistant to degradation. Said method includes steps of: a) taking two or more antibodies, b) each residue Asn and Asp in the Fv domain of the antibody is determined conformational mobility Cα-atom using ensemble of models based on homology, c) each residue of Asn and Asp in the Fv antibody domain is used to determine the size of the amino acid residue adjacent to the Asn or Asp residue from the C-terminal side, d) selecting one or more antibodies in which Cα-atom is conformationally fixed and in which on the C-end side to Asn or Asp adjoins an amino acid residue with a surface area accessible to solvent of 111 Å2 or more, where the conformational mobility is the mean-square deviation (RMSD) of the corresponding Cα-atoms of Asn/Asp residues in an ensemble of models based on homology.

EFFECT: invention enables efficient selection of one or more antibodies resistant to degradation.

1 cl, 8 dwg, 3 tbl, 8 ex

Similar patents RU2711719C2

Title Year Author Number
ANTIBODIES BINDING IL-4 AND/OR BL-13 AND THEIR APPLICATION 2008
  • Rao Ehrkole
  • Mikol' Vensan
  • Li Dan'Si
  • Krujp Jokhen
  • Dehvison Mett'Ju
RU2488595C2
ANTIBODIES BINDING IL-4 AND/OR IL-13, AND THEIR USE 2015
  • Rao Erkole
  • Mikol Vensan
  • Li Dansi
  • Krujp Jokhen
  • Devison Mettyu
RU2721236C2
ANTIBODIES BINDING IL-4 AND/OR IL-13, AND USE THEREOF 2015
  • Rao Erkole
  • Mikol Vensan
  • Li Dansi
  • Krujp Jokhen
  • Devison Mettyu
RU2705551C2
IL-4 AND/OR IL-13 BINDING ANTIBODIES AND USING THEM 2008
  • Rao Erkole
  • Mikol Vensan
  • Li Dansi
  • Krujp Jokhen
  • Devison Mettju
RU2580049C2
HUMANIZED IMMUNE BODIES FOR CXCR5, THEIR SECONDARIES, AND THEIR USE 2008
  • Li Renata
  • Mikol' Vensan
  • Allen Ehlizabet
  • Rjuch Norman
  • Kameron Beatris
  • Olidzhino Tomas
  • Boren Nikolja
RU2571515C2
ANTI-TFR ANTIBODIES AND USE THEREOF IN TREATING PROLIFERATIVE AND INFLAMMATORY DISORDERS 2016
  • Launay, Pierre
  • Belanger, Coralie
  • Souchet, Herve
RU2737637C2
ANTI-IGE ANTIBODIES 2017
  • Adams, Ralf
  • Cheska, Tomas Allen
  • Devis, Anna Mari
  • Genri, Alister Dzhejms
  • Lyu, Syaofen
  • Makdonnell, Dzhejms Majkl
  • Satton, Brajan Dzhon
  • Vestvud, Marta Katazhina
RU2816207C2
ISOLATED HUMANIZED PROTEIN BINDING TO HUMAN GLYCOPROTEIN VI, ISOLATED ANTIBODY BINDING TO HUMAN GLYCOPROTEIN VI 2018
  • Bilalde, Filip
  • Zhanro-Perrus, Martine
  • Avenar, Zhiles
RU2778884C2
PROTEIN BOUND WITH HUMAN GLYCOPROTEIN, COMPOSITION, PHARMACEUTICAL COMPOSITION, EXPRESSION VECTOR 2016
  • Bilalde Filip
  • Zhanro-Perrus Martine
RU2773819C2
HUMANIZED ANTIBODIES SPECIFIC TO ALPHA-ENOLASE AND METHODS FOR USE IN ANTITUMOR THERAPY 2014
  • Chen, Li-Tzong
  • Liu, Ko-Jiunn
  • Shih, Neng-Yao
  • Wu, Chung-Hsiun
  • Lok, Ying-Yung
  • Tsai, Ya-Wei
  • Huang, Chao-Yang
  • Wu, Chia-Cheng
  • Lai, Jiann-Shiun
  • Tseng, Shih-Chi
  • Yuan, Ta-Tung
  • Tsai, Shih-Chong
RU2761662C2

RU 2 711 719 C2

Authors

Kettenberger Gubert

Klostermann Shtefan

Lipsmajer Florian

Papadimitriou Apollon

Syudov-Andersen Zhasmin

Dates

2020-01-21Published

2014-09-03Filed